Table 1.
Psychiatric comorbidity | Yes | No | p-value |
---|---|---|---|
Time of evolution of the epileptic seizures (yr) | 0.609 | ||
0–10 | 51 (63.7) | 29 (36.2) | |
11–20 | 16 (72.7) | 6 (27.3) | |
>20 | 27 (71.1) | 11 (28.9) | |
Epileptic seizures | 0.370 | ||
Focal | 82 (66.1) | 42 (33.9) | |
Focal+generalized | 5 (100.0) | 0 (0.0) | |
Generalized | 7 (63.6) | 4 (36.4) | |
Focal | 0.799 | ||
Disperceptive | 16 (66.7) | 8 (33.3) | |
Focal evolving to bilateral tonic-clonic | 56 (67.5) | 27 (32.5) | |
Perceptive | 7 (53.8) | 6 (46.2) | |
Perceptive+disperceptive | 3 (75.0) | 1 (25.0) | |
Generalized | 1 | ||
Motor | 5 (55.6) | 4 (44.4) | |
Motor+non-motor (absence) | 1 (100.0) | 0 (0.0) | |
Non-motor (absence) | 1 (100.0) | 0 (0.0) | |
MRI finding | 0.381 | ||
Hippocampus asymmetry | 9 (75.0) | 3 (25.0) | |
Cerebral atrophy | 6 (54.5) | 5 (45.5) | |
Calcifications | 1 (50.0) | 1 (50.0) | |
Encephalomalaceae/gliosis | 1 (100.0) | 0 (0.0) | |
Mesial temporal sclerosis | 22 (78.6) | 6 (21.4) | |
Ischemia | 4 (66.7) | 2 (33.3) | |
Malformation | 1 (100.0) | 0 (0.0) | |
Sequel encephalitis | 0 (0.0) | 1 (100.0) | |
Tumor | 5 (100.0) | 0 (0.0) | |
Epilepsy syndrome | 0.245 | ||
Unknown | 2 (40.0) | 3 (60.0) | |
Focal | 80 (67.2) | 39 (32.8) | |
Combined focal and generalizated | 5 (100.0) | 0 (0.0) | |
Generalized | 7 (63.6) | 4 (36.4) | |
Seizures control | 0.009 | ||
Controlled | 74 (62.7) | 35 (32.1) | |
Inactive | 13 (100.0) | 0 (0.0) | |
Not controlled | 16 (88.9) | 2 (11.1) | |
Therapy with AEDs | 0.392 | ||
Monotherapy | 51 (65.4) | 27 (34.6) | |
Politherapy | 30 (75.0) | 10 (25.0) | |
Without AED | 13 (59.1) | 9 (40.9) |
Values are presented as number (%).
MRI, magnetic resonance imaging; AED, antiepileptic drug.